mAb therapies

Monoclonal antibody (mAb) therapies are specially designed proteins that target specific parts of the body, such as disease-causing agents like viruses or cancer cells. They are created in the lab to recognize and bind to unique markers on these targets, helping the immune system identify and attack them more effectively. mAbs can be used to treat a variety of conditions, including cancers, autoimmune diseases, and infections, by either blocking harmful processes or marking harmful cells for destruction. They are a precise, targeted approach that can improve treatment effectiveness with generally fewer side effects.